Ludwig Hantson

Insider Reports History

Entity
Individual
Location
C/O Alexion Pharmaceuticals, Inc, 100 College Street, New Haven, CT
Signature
/s/ Mark W. Irving, attorney-in-fact for Dr. Hantson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ludwig Hantson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALEXION PHARMACEUTICALS, INC. CEO, Director Common Stock, par value $.0001 per share 9.1K $1.61M $177.00 Jul 21, 2021 Direct
HOLOGIC INC Director Common Stock 11.1K $845K $76.21 Mar 7, 2024 Direct
HOLOGIC INC Director Non-qualified Stock Option (Right to Buy) 4.54K Mar 7, 2024 Direct
ALEXION PHARMACEUTICALS, INC. CEO, Director Option to Purchase Common Stock 0 $155.01 Jul 21, 2021 Direct

Insider Reports Filed by Ludwig Hantson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HOLX HOLOGIC INC Mar 7, 2024 2 $0 4 Mar 11, 2024 Director
HOLX HOLOGIC INC Mar 9, 2023 2 $0 4 Mar 13, 2023 Director
HOLX HOLOGIC INC Mar 10, 2022 2 $0 4 Mar 14, 2022 Director
ALXN ALEXION PHARMACEUTICALS, INC. Jul 21, 2021 2 -$6.75M 4 Jul 23, 2021 CEO, Director
ALXN ALEXION PHARMACEUTICALS, INC. Jul 14, 2021 2 $0 4 Jul 16, 2021 CEO, Director